Literature DB >> 16597859

Is serological testing a reliable tool in laboratory diagnosis of syphilis? Meta-analysis of eight external quality control surveys performed by the german infection serology proficiency testing program.

Iris Müller1, Volker Brade, Hans-Jochen Hagedorn, Erich Straube, Christoph Schörner, Matthias Frosch, Harald Hlobil, Gerold Stanek, Klaus-Peter Hunfeld.   

Abstract

The accuracy of diagnostic tests is critical for successful control of epidemic outbreaks of syphilis. The reliability of syphilis serology in the nonspecialist laboratory has always been questioned, but actual data dealing with this issue are sparse. Here, the results of eight proficiency testing sentinel surveys for diagnostic laboratories in Germany between 2000 and 2003 were analyzed. Screening tests such as Treponema pallidum hemagglutination assay (mean accuracy, 91.4% [qualitative], 75.4% [quantitative]), Treponema pallidum particle agglutination assay (mean accuracy, 98.1% [qualitative], 82.9% [quantitative]), and enzyme-linked immunosorbent assays (ELISAs) (mean qualitative accuracy, 95%) were more reliable than Venereal Disease Research Laboratory (VDRL) testing (mean accuracy, 89.6% [qualitative], 71.1% [quantitative]), the fluorescent treponemal antibody absorption test (FTA-ABS) (mean accuracy, 88% [qualitative], 65.8% [quantitative]), and immunoblot assays (mean qualitative accuracy, 87.3%). Clearly, immunoglobulin M (IgM) tests were more difficult to manage than IgG tests. False-negative results for samples that have been unambiguously determined to be IgM and anti-lipoid antibody positive accounted for 4.7% of results in the IgM ELISA, 6.9% in the VDRL test, 18.5% in the IgM FTA-ABS, and 23.0% in the IgM immunoblot assay. For negative samples, the mean percentage of false-positive results was 4.1% in the VDRL test, 5.4% in the IgM ELISA, 0.7% in the IgM FTA-ABS, and 1.4% in the IgM immunoblot assay. On average, 18.3% of participants misclassified samples from patients with active syphilis as past infection without indicating the need for further treatment. Moreover, 10.2% of laboratories wrongly reported serological evidence for active infection in samples from patients with past syphilis or in sera from seronegative blood donors. Consequently, the continuous participation of laboratories in proficiency testing and further standardization of tests is strongly recommended to achieve better quality of syphilis serology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16597859      PMCID: PMC1448642          DOI: 10.1128/JCM.44.4.1335-1341.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Quality assurance in clinical laboratories in Taiwan.

Authors:  W S Hsu; J T Kao; S W Ho
Journal:  J Formos Med Assoc       Date:  2000-03       Impact factor: 3.282

2.  Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results.

Authors:  R W Peeling; S P Wang; J T Grayston; F Blasi; J Boman; A Clad; H Freidank; C A Gaydos; J Gnarpe; T Hagiwara; R B Jones; J Orfila; K Persson; M Puolakkainen; P Saikku; J Schachter
Journal:  J Infect Dis       Date:  2000-06       Impact factor: 5.226

3.  Serological diagnosis of syphilis. PHLS Syphilis Serology Working Group.

Authors:  S I Egglestone; A J Turner
Journal:  Commun Dis Public Health       Date:  2000-09

4.  Center for Disease Control Diagnostic Immunology Proficiency Testing Program results for 1977.

Authors:  R N Taylor; K M Fulford; V A Przybyszewski; V Pope
Journal:  J Clin Microbiol       Date:  1978-10       Impact factor: 5.948

5.  Report of a collaborative study to establish the international standard for parvovirus B19 serum IgG.

Authors:  M Ferguson; D Walker; B Cohen
Journal:  Biologicals       Date:  1997-09       Impact factor: 1.856

6.  Assessment of laboratory improvement by the Center for Disease Control Diagnostic Immunology Proficiency Testing Program.

Authors:  R N Taylor; K M Fulford
Journal:  J Clin Microbiol       Date:  1981-02       Impact factor: 5.948

7.  Quality of Lyme disease serology. Lessons from the German Proficiency Testing Program 1999-2001. A preliminary report.

Authors:  Klaus-Peter Hunfeld; Gerold Stanek; Eberhard Straube; Hans-Jochen Hagedorn; Christoph Schörner; Fritz Mühlschlegel; Volker Brade
Journal:  Wien Klin Wochenschr       Date:  2002-07-31       Impact factor: 1.704

8.  Prevalence of STDs among prostitutes in Czech border areas with Germany in 1997-2001 assessed in project "Jana".

Authors:  V Resl; M Kumpová; L Cerná; M Novák; P Pazdiora
Journal:  Sex Transm Infect       Date:  2003-12       Impact factor: 3.519

9.  The United Kingdom national microbiological quality assessment scheme.

Authors:  J J Snell; J V De Mello; P S Gardner
Journal:  J Clin Pathol       Date:  1982-01       Impact factor: 3.411

10.  Primary and secondary syphilis--United States, 2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-11-21       Impact factor: 17.586

View more
  13 in total

1.  Musculoskeletal involvement of syphilis--a forgotten lesson.

Authors:  Jesus Vallejo Gomez; Szabolcs Lajos Molnar; Sami Mansour Val; Rafael Gracia Arnal
Journal:  BMJ Case Rep       Date:  2012-07-11

2.  Evaluation of test results of microbiology laboratories of North India for standard tests for syphilis under an external quality assurance scheme.

Authors:  S M Gupta; M Bala; S Muralidhar; K Ray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-11-01       Impact factor: 3.267

3.  External quality assessment of pertussis serology in Germany.

Authors:  M Riffelmann; K-P Hunfeld; I Müller; D Xing; N Kennerknecht; C H Wirsing von König
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-10-19       Impact factor: 3.267

4.  Establishment and Evaluation of a One-Step Microplate Chemiluminescence Immunoassay to Detect IgG Antibody Against Treponema Pallidum.

Authors:  Lijuan Liu; Yuling Xie; Zhenxian Dai; Chuanshang Zhuo; Yushui Wu
Journal:  J Clin Lab Anal       Date:  2014-10-02       Impact factor: 2.352

5.  Decline in the workload associated with the serodiagnosis of syphilis in a general hospital: 1994-2004.

Authors:  A Burillo; C Fernández-Pérez; M Rivera; R Alonso; P Catalán; E Bouza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-28       Impact factor: 3.267

6.  Italian national survey of blood donors: external quality assessment (EQA) of syphilis testing.

Authors:  Francesca Vulcano; Luisa Milazzo; Sabrina Volpi; Mara Maria Battista; Alessandra Barca; Hamisa Jane Hassan; Fulvia Pimpinelli; Adele Giampaolo
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

Review 7.  Syphilis.

Authors:  Rosanna W Peeling; David Mabey; Mary L Kamb; Xiang-Sheng Chen; Justin D Radolf; Adele S Benzaken
Journal:  Nat Rev Dis Primers       Date:  2017-10-12       Impact factor: 52.329

8.  Evaluating frequency, diagnostic quality, and cost of Lyme borreliosis testing in Germany: a retrospective model analysis.

Authors:  I Müller; M H Freitag; G Poggensee; E Scharnetzky; E Straube; Ch Schoerner; H Hlobil; H-J Hagedorn; G Stanek; A Schubert-Unkmeir; D E Norris; J Gensichen; K-P Hunfeld
Journal:  Clin Dev Immunol       Date:  2011-12-27

Review 9.  Efforts in blood safety: Integrated approach for serological diagnosis of syphilis.

Authors:  Linda Sommese; Maria Rosaria De Pascale; Maria Capuano; Claudio Napoli
Journal:  Asian J Transfus Sci       Date:  2016 Jan-Jun

10.  Serologic Response to Treatment in Human Immunodeficiency Virus-Negative Syphilis Patients Using Automated Serological Tests: Proposals for New Guidelines.

Authors:  Jung-In Kim; Ji-Hye Park; Ju-Yeon Choi; Ga-Young Lee; Won-Serk Kim
Journal:  Ann Dermatol       Date:  2017-10-30       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.